Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Krystal Biotech Inc | KRYS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 159.05 | 04:24:25 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 159.05 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 82.09 - 189.97 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 159.05 | USD |
Krystal Biotech (KRYS) Options Flow Summary
Krystal Biotech Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.5B | 28.29M | - | 50.7M | 10.93M | 0.39 | 411.62 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Krystal Biotech News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KRYS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 167.97 | 171.455 | 155.91 | 159.93 | 285,088 | -8.92 | -5.31% |
| 1 Month | 176.49 | 182.51 | 155.91 | 171.79 | 265,524 | -17.44 | -9.88% |
| 3 Months | 111.96 | 189.97 | 107.50 | 156.58 | 397,782 | 47.09 | 42.06% |
| 6 Months | 115.78 | 189.97 | 93.95 | 135.58 | 358,299 | 43.27 | 37.37% |
| 1 Year | 85.00 | 189.97 | 82.09 | 126.81 | 324,019 | 74.05 | 87.12% |
| 3 Years | 78.59 | 189.97 | 38.8563 | 94.93 | 242,335 | 80.46 | 102.38% |
| 5 Years | 33.05 | 189.97 | 22.02 | 81.07 | 209,068 | 126.00 | 381.24% |
Krystal Biotech Description
| Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. |
